Study of injection Depomedroxyprogesterone acetate (DMPA) at tertiary care teaching hospital
|
Swati Gurav * 1, Uma Wankhede2 |
1- BJGMC PUNE , swati.gurav2009@gmail.com 2- BJGMC PUNE |
|
Abstract: (1209 Views) |
Background: Injectable Contraceptive is fourth most popular family planning method worldwide after
female sterilization, intra uterine contraceptive device & oral contraceptive. Postpartum contraception
is crucial for health of women.
METHOD:-
This was retrospective study from 1 st Jan 2020 to 31st August 2021 at tertiary care teaching hospital in pune
Aim of study was to know demographic details of DMPA (Depot Metroxy Progesterone Acetate)
users, side effects & compliance of Inj DMPA. Medical record of 223 women who opted for Inj DMPA after counseling regarding contraceptive options was studied.
RESULTS:-
Most common side effect observed in Inj DMPA users was menstrual disorder irregular bleeding 62.3%
followed by weight gain, amenorrhea & headache in 9.4%,1.7% & 1.3% women respectively. 24.66%
women were para one while majority of DMPA users belonged to 21 to 25 years of age group.
CONCLUSION:-
MPA is highly effective, safe, long term reversible contraceptive option. Proper counseling if done
before & after administration of Inj DMPA lead to better patient compliance
|
|
Keywords: DMPA, postpartum contraception, family planning |
|
|
Type of Study: Original Article |
Subject:
Clinical Medicine Received: 2023/12/17 | Accepted: 2024/06/11 | Published: 2024/06/11
|
|
|
|
|
Add your comments about this article |
|
|